What question did this study set out to answer?

The aim is to examine the role of prognostic biomarkers and phytocompound therapies in colorectal cancer (CRC) treatment.

March 1, 2026

A review on prognostic biomarker and phytocompound-mediated modulation of signaling pathways in colorectal cancer.

Key Points

The aim is to examine the role of prognostic biomarkers and phytocompound therapies in colorectal cancer (CRC) treatment.
Review of existing literature on biomarkers and phytocompounds
Analysis of signaling pathways involved in CRC
Evaluation of drug delivery methods and multi-omics strategies
Phytocompounds show promise in modulating cancer-related signaling pathways
Biomarker profiling can enhance treatment accuracy and reduce side effects
Further clinical validation and integration of multi-omics are necessary for advancing CRC therapy.

Abstract

The integration of molecular biomarker profiling with phytocompound-based therapies has the potential to enable more accurate CRC treatments with minimal adverse effects. The future of cancer research should be aimed at clinical validation, better drug delivery and multi-omics integration.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Krishnakumar et al. (Thu,) studied this question.

synapsesocial.com/papers/69a3d7dfec16d51705d2e4be — DOI: https://doi.org/10.1080/17410541.2026.2634747

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Microsatellite Instability with BRAF V600E Associated with Delayed Presentation but Poor Survival in Stage III Colorectal Cancer· 2023 · 2 citations
Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6/JAK2/STAT3 signaling· 2018 · 258 citations
Bioavailability of phytochemicals and its enhancement by drug delivery systems· 2013 · 386 citations
Protocol for MInimizing the Risk of Metachronous Adenomas of the CoLorectum with Green Tea Extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population· 2011 · 54 citations
Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities· 2018 · 199 citations

Authors

Bhavyaa Krishnakumar

Benedict Christopher Paul

Sri Ramachandra Institute of Higher Education and Research

Sabina Evan Prince

Actions

Institutions

Vellore Institute of Technology University

Sri Ramachandra Institute of Higher Education and Research

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

A review on prognostic biomarker and phytocompound-mediated modulation of signaling pathways in colorectal cancer.

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Authors

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Also consider